30 results
DEF 14A
NTBL
Notable Labs Ltd
16 Feb 24
Definitive proxy
9:00am
time to time in order to ensure that levels of executive compensation, as compared to the overall workforce will not have a negative impact on work
PRE 14A
NTBL
Notable Labs Ltd
5 Feb 24
Preliminary proxy
5:00pm
to be examined by Notable from time to time in order to ensure that levels of executive compensation, as compared to the overall workforce
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
result in a suspension of trading and possible delisting.
VBL has undergone a significant workforce reduction to reduce operating expenses … reduced its workforce and currently has only seven full-time employees. As part of the organizational streamlining, Dr. Ron Cohen, Dr. Bennett
S-4/A
9lkdv
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
10-Q
qunm03 pr4ic6
15 May 23
Quarterly report
4:30pm
S-4
5u505d0e58gyyv
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.1
zly0y
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.2
08fua
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.3
idux je4nm5r8mb3o
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.3
yuhia6mby
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
EX-99.1
nxpj0z fbly324
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
EX-99.2
dwilsiwf
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
l5t pwd3xlacm2r
2 Aug 22
VBL Therapeutics Announces Workforce Reduction
8:32am
6-K
EX-99.1
532vii9 a488v7
2 Aug 22
VBL Therapeutics Announces Workforce Reduction
8:32am